- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/06 - Antimigraine agents
Patent holdings for IPC class A61P 25/06
Total number of patents in this class: 1251
10-year publication summary
|
40
|
44
|
45
|
89
|
87
|
123
|
122
|
118
|
116
|
30
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 213 |
46 |
| H. Lundbeck A/S | 1252 |
36 |
| Merck Sharp & Dohme LLC | 3689 |
33 |
| Boehringer Ingelheim International GmbH | 4629 |
28 |
| Eli Lilly and Company | 3645 |
28 |
| Allergan Pharmaceuticals International Limited | 253 |
23 |
| Bristol-myers Squibb Company | 5080 |
19 |
| Takeda Pharmaceutical Company Limited | 2961 |
19 |
| Amgen Inc. | 3779 |
18 |
| F. Hoffmann-La Roche AG | 7958 |
16 |
| Raqualia Pharma Inc. | 119 |
15 |
| Hoffmann-La Roche Inc. | 3060 |
11 |
| Janssen Pharmaceutica N.V. | 3839 |
11 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 154 |
11 |
| Allergan, Inc. | 2600 |
10 |
| Heptares Therapeutics Limited | 225 |
9 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
9 |
| Teva Pharmaceuticals International GmbH | 355 |
9 |
| Intra-Cellular Therapies, Inc. | 378 |
8 |
| Vertex Pharmaceuticals Incorporated | 1581 |
7 |
| Other owners | 885 |